🔎 Trials Near Me

Utama › Kanser Darah › Wisconsin › Milwaukee

Kajian klinikal Kanser Darah di Milwaukee, WI

12 kajian untuk Kanser Darah sedang mencari peserta di lokasi dalam dan sekitar Milwaukee (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • dan 9 lagi
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Mengambil pesertaKajian pemerhatian
  • Children's Hospital of Wisconsin, Milwaukee
Umur 0 hingga 38 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06131801

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Mengambil pesertaFasa 3
  • Medical College of Wisconsin, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07648264

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Mengambil pesertaKajian pemerhatian
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Ascension Southeast Wisconsin Hospital-Saint Joseph-Milwaukee, Milwaukee
  • Ascension Columbia Saint Mary's Hospital-Milwaukee Campus, Milwaukee
  • dan 14 lagi
Semua umur · Semua jantina · Dikemas kini 17 Sep 2026 · NCT04242095

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Mengambil pesertaFasa 3
  • Froedtert & Medical College of Wisconsin, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Mengambil pesertaFasa 1
  • Froedtert & Medical College Clinics, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT06001788

Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors

Mengambil pesertaKajian pemerhatian
  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT04892823

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Mengambil pesertaKajian pemerhatian
  • Children's Hospital of Wisconsin, Milwaukee
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

Mengambil pesertaKajian pemerhatian
  • Children's Hospital of Wisconsin., Milwaukee
Sehingga umur 30 · Semua jantina · Dikemas kini 18 Jun 2026 · NCT06579469

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Mengambil pesertaFasa 1
  • Medical College of Wisconsin Cancer Center, Milwaukee
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Mac 2026 · NCT05735184

CIBMTR Research Database

Mengambil pesertaKajian pemerhatian
  • Medical College of Wisconsin, Milwaukee
Semua umur · Semua jantina · Dikemas kini 12 Ogo 2025 · NCT01166009

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Mengambil pesertaFasa 1
  • Children's Hospital of Wisconsin, Milwaukee
Umur 1 hingga 21 · Semua jantina · Dikemas kini 6 Dis 2024 · NCT05476770

Kajian Kanser Darah di bandar lain

Kajian lain di Milwaukee

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.